Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
1.
Pediatr Neonatol ; 2024 Mar 16.
Article in English | MEDLINE | ID: mdl-38514358

ABSTRACT

BACKGROUND: Newborns with critical congenital heart disease (CCHD) with increased pulmonary blood flow (PBF) are at high risk for congestive heart failure. In this study, we aimed to evaluate the presence and degree of pulmonary edema in newborns with CCHD using lung ultrasound (LUS) during the perioperative period. METHODS: Prospective clinical trial, 44 newborn patients with CCHD were evaluated in this prospective clinical trial. LUS was repeatedly performed to determine the course of pulmonary edema during the perioperative period. LUS was performed simultaneously with chest radiography (CXR), which was the main part of patient management. The primary outcome of this study was to identify whether a correlation existed between LUS and CXR findings. The secondary outcomes were to determine the relationship between LUS and the need for respiratory support, diuretic use, vasoactive inotropic score (VIS), and pro-B-type natriuretic peptide (pro-BNP) levels during the perioperative period. RESULTS: The mean gestational age of the patients was 38.3 ± 1.7 weeks, with a mean birth weight of 3026 ± 432 g. In the preoperative period, both LUS and CXR images were consistent with clinical signs of pulmonary edema. On the first postoperative day, pulmonary edema increased compared to the preoperative period but gradually decreased by the 6th day of surgery (p < 0.05). Positive correlations were observed between the LUS and CXR findings at all study points (p < 0.05). The LUS findings exhibited trends parallel to those of VIS, serum pro-BNP levels, need for respiratory support, and diuretic requirements. As expected, these trends were more pronounced in CCHDs where PBF increased. CONCLUSION: In CCHD, serial lung ultrasound (LUS) assessments, particularly in cases with increased PBF, can provide valuable guidance for managing patients during the perioperative period.

2.
Cardiol Young ; 34(2): 445-447, 2024 Feb.
Article in English | MEDLINE | ID: mdl-38105572

ABSTRACT

INTRODUCTION: Congenital junctional ectopic tachycardia is a rare arrhythmia that occurs in patients without previous cardiac surgery. In this report, we wanted to present a 6-hour-old newborn with congenital junctional ectopic tachycardia resistant to conventional anti-arrhythmic medications, who was successfully treated with ivabradine and amiadarone combination. CASE: A six-hour-old newborn girl was hospitalised in neonatal ICU because transient tachypnoea of the newborn. She was tachycardic, and supraventricular tachycardia was noticed. There was no answer to the adenosine esmolol treatment; even synchronised direct cardioversion intravenous amiodarone was started. Junctional ectopic tachycardia was diagnosed. We have added propranolol to the treatment and followed patient for 2 days. On the fourth day, junctional ectopic tachycardia rhythm still persisted; therefore, ivabradine treatment was added to the treatment. On the following day, the heart rhythm was slowed to 110/min, and propranolol was stopped; intravenous amiodarone treatment was changed to the oral form. The rhythm turned into sinus; two days after starting ivabradine and oral amiodarone. CONCLUSION: Tachyarrhythmia originating in the atrioventricular node and atrioventricular junction including the bundle of His complex are junctional ectopic tachycardia. Congenital junctional ectopic tachycardia is rare, and it is mostly resistant to the conventional treatment.Ivabradine is a new anti-arrhythmic agent, used extensively to decrease sinus rate in the treatment of cardiac failure. Ivabradine may be an option for the resistant congenital ectopic tachycardia.


Subject(s)
Amiodarone , Tachycardia, Ectopic Junctional , Infant, Newborn , Female , Humans , Ivabradine/therapeutic use , Anti-Arrhythmia Agents/therapeutic use , Tachycardia, Ectopic Junctional/diagnosis , Tachycardia, Ectopic Junctional/drug therapy , Propranolol/therapeutic use , Amiodarone/therapeutic use
3.
Cardiol Young ; 33(10): 2049-2053, 2023 Oct.
Article in English | MEDLINE | ID: mdl-36517980

ABSTRACT

Many studies have been conducted to determine the most reliable technique for evaluating the position of the endotracheal tube in patients receiving mechanical ventilation support. In this study, we aimed to determine the endotracheal tube position by ultrasonography in intubated patients with a diagnosis of critical CHD followed in the neonatal ICU. METHODS: In this prospective observational clinical study, we performed point-of-care ultrasound for endotracheal tube localisation in 65 intubated newborns with critical CHD. After routine radiography, each patient underwent point-of-care ultrasound examination with a portable ultrasonography device for endotracheal tube end-carina measurement. Endotracheal tube end-carina measurements on chest radiographs were compared with ultrasound images. RESULTS: The mean gestational age and birth weight were 37.8 ± 2.19 weeks and 2888 ± 595 g, respectively. Ultrasound images were obtained after an average of 2.08 ± 1.6 hours from the radiographs. The average ultrasound time allocated to each patient was 5 minutes. The mean endotracheal tube tip-to-carina distance on chest X-ray and ultrasound were optimally 1.33 ± 0.64 cm and 1.43 ± 0.67 cm, respectively. There was no significant difference between chest X-ray and ultrasound measurements in endotracheal tube end-carina distance values evaluated by the Bland-Altman method (mean difference 0.10 cm, p = 0.068). There was a linear correlation between the endotracheal tube tip-carina distance in ultrasound and radiography evaluation (r2 = 0.60, p < 0.001). CONCLUSION: It has been concluded that critical CHDs are frequently accompanied by vascular anomalies, and the endotracheal tube tip-carina distance measurement can be used by determining the carina section as a guide point in the ultrasonographic evaluation of the endotracheal tube location in this patient population.


Subject(s)
Intubation, Intratracheal , Trachea , Humans , Infant, Newborn , Birth Weight , Gestational Age , Respiration, Artificial , Trachea/diagnostic imaging , Prospective Studies
4.
Am J Perinatol ; 40(5): 567-574, 2023 04.
Article in English | MEDLINE | ID: mdl-35790179

ABSTRACT

OBJECTIVE: The causative agent of the severe acute respiratory syndrome is a new type of coronavirus infection called coronavirus disease-2019 (COVID-19) which has spread around the world. COVID-19 is thought to rarely affect infants, so pandemic planning focuses on adults. This study aimed to share our 1-year experience with COVID-19-positive newborns in a tertiary neonatal intensive care unit (NICU). STUDY DESIGN: Hospitalized newborns after a reverse transcription polymerase chain reaction (RT-PCR) for COVID-19 were evaluated in this retrospective, cohort study between March 2020 and March 2021. The clinical course, laboratory tests, imaging studies, and outcomes of affected newborns were collected from medical records. RESULTS: Eleven COVID-19-diagnosed newborns were analyzed in our study. Four (36.6%) patients had contact with a COVID-19-positive individual in their families. The main symptoms were fever (81.8%), hypoxemia (63.6%), and tachypnea (63.6%). Bacterial coinfection was identified in two newborns. Aortic coarctation was detected as an accompanied disease by a newborn who was referred to our hospital with a suspicion of congenital heart disease and two patients had a bacterial coinfection. We did not detect any cases of neonatal multisystem inflammatory syndrome. All patients were discharged in good health. None of the newborns had any complications and repeated infection with another variant during the first-year follow-up. CONCLUSION: Contrary to popular belief, newborns are a sensitive age group for COVID-19 and need a high rate of hospitalization. Congenital heart diseases and coinfections should not be overlooked in COVID-19-infected newborns. The acquired immunity due to COVID-19 infection protects newborns from recurrent COVID-19 infections in their first year of life. The absence of COVID-19-positive individual in the family in most cases suggests that PCR-negative adults may also play a role in the transmission of the disease. KEY POINTS: · COVID-19 is still a pandemic all over the world.. · COVID-19 is dangerous for newborns.. · PCR-negative adults may also play a role in the transmission of the disease to the newborn..


Subject(s)
COVID-19 , Coinfection , Pregnancy Complications, Infectious , Adult , Infant , Humans , Infant, Newborn , Pregnancy , Female , SARS-CoV-2 , Cohort Studies , Retrospective Studies
5.
Am J Perinatol ; 2022 Oct 01.
Article in English | MEDLINE | ID: mdl-36181758

ABSTRACT

OBJECTIVE: Aim of this study is to investigate the diagnostic role of the systemic immune-inflammation index (SII; neutrophil × platelet [PLT]/lymphocyte) in the prediction of renal involvement in newborns with urinary tract infection (UTI). STUDY DESIGN: We conducted a retrospective cohort study among 117 newborns with a gestational age greater than 35 weeks and hospitalized in the NICU. Laboratory values obtained from blood samples taken before the initiation of antibiotics were evaluated for renal function tests, complete blood count, and acute phase reactants. The ratios of platelet-to-lymphocyte (PLR), neutrophil-to-lymphocyte (NLR), and SII were calculated. The patients were divided into two main groups according to the presence of urinary tract pathology in ultrasonography (US): group 1, UTI with renal involvement (n = 43) and group 2, UTI without renal involvement (n = 74). Predictive values of different tests were compared. RESULTS: The mean white blood cell, PLT, mean PLT volume, and neutrophile counts were higher, while lymphocyte counts were significantly lower in group 1 than those of group 2. Interleukin 6 (IL-6; pg/mL; IL-6), C-reactive protein (CRP; mg/L), NLR, PLR, and SII values were also higher in group 1. Receiver operating characteristics curve showed that SII, CRP, IL-6, PLR, and NLR have a predictive ability to discriminate renal involvement from normal renal findings in newborns with UTI. The SII produced an area under curve of 0.75 (72% sensitivity and 60.8% specificity). To define renal involvement, the cut-off values of SII, CRP, IL-6, PLR, and NLR were 217, 3.06, 23, 65.5, and 0.60, respectively. CONCLUSION: Our results showed that SII might be used as an additional parameter in the prediction of renal involvement in newborns with UTIs. Further studies are required. KEY POINTS: · Most UTIs in newborns present with upper UTI rather than simple cystitis.. · Some inflammatory markers can be used for the diagnosis of UTIs.. · SII may be useful in the prediction of urinary tract infections..

6.
Proc (Bayl Univ Med Cent) ; 35(4): 567-568, 2022.
Article in English | MEDLINE | ID: mdl-35754590

ABSTRACT

Usually, swallowing of maternal blood is the cause of bloody vomiting in healthy term newborns. Other reported causes include gastritis, esophagitis, gastric ulcer, and duodenal ulcer. We report a newborn girl born by cesarean at 372/7 weeks who had hematemesis on postnatal day 1 and hematochezia on day 2. An erythrocyte transfusion was given on day 3. Gastroscopy performed on day 4 showed multiple gastric ulcers. Antacid treatment was given. On day 12, the newborn had a good general condition and stable vital signs and was discharged. Gastric ulcer needs to be considered as the etiology of hematemesis in healthy term newborns.

7.
Cardiol Young ; 32(5): 702-704, 2022 May.
Article in English | MEDLINE | ID: mdl-34294189

ABSTRACT

INTRODUCTION: Congenital atrioventricular block is diagnosed in uterine life, at birth, or early in life. Atrioventricular blocks can be life threatening immediately at birth so urgent pacemaker implantation techniques are requested. Reasons can be cardiac or non-cardiac, but regardless of the reason, operations are challenging. We aimed to present technical procedure and operative results of pacemaker implantation in neonates. MATERIALS AND METHODS: Between June 2014 and February 2021, 10 neonates who had congenital atrioventricular block underwent surgical operation to implant permanent epicardial pacemaker by using minimally invasive technique. Six of the patients were female and four of them were male. Mean age was 4.3 days (0-11), while three of them were operated on the day of birth. Mean weight was 2533 g (1200-3300). RESULTS: Operations were achieved through subxiphoidal minimally skin incision. Epicardial 25 mm length dual leads were implanted on right ventricular surface and generators were fixed on the right (seven patients) or left (three patients) diaphragmatic surface by incising pleura. There were no complication, morbidity, and mortality related to surgery. CONCLUSION: Few studies have characterised the surgical outcomes following epicardial permanent pacemaker implantation in neonates. The surgical approach is attractive and compelling among professionals so we aimed to present the techniques and results in patients who required permanent pacemaker implantation in the first month of life.


Subject(s)
Atrioventricular Block , Cardiac Surgical Procedures , Pacemaker, Artificial , Atrioventricular Block/etiology , Cardiac Pacing, Artificial/methods , Cardiac Surgical Procedures/adverse effects , Child, Preschool , Delivery Rooms , Female , Humans , Infant, Newborn , Male , Pacemaker, Artificial/adverse effects , Pregnancy
8.
Echocardiography ; 38(4): 716-717, 2021 04.
Article in English | MEDLINE | ID: mdl-33677831

ABSTRACT

Congenital aneurysm of the ductus arteriosus is reported in 0.8% in neonatal autopsies; however, true incidence is unknown because of high rate of asymptomatic cases and spontaneous regression. Possible complications in symptomatic cases are thromboembolism, spontaneous rupture, erosion, infection, compression of airways, and death. In this report, we present a newborn with giant ductus arteriosus aneurysm (DAA) diagnosed in first day of life, surgically treated after thrombosis of aneurysm.


Subject(s)
Aneurysm , Ductus Arteriosus, Patent , Ductus Arteriosus , Thrombosis , Ductus Arteriosus/diagnostic imaging , Humans , Infant, Newborn , Thrombosis/diagnostic imaging
9.
J Matern Fetal Neonatal Med ; 34(10): 1522-1528, 2021 May.
Article in English | MEDLINE | ID: mdl-31268367

ABSTRACT

BACKGROUND AND AIM: The thiol-disulfide homeostasis is essential for the body to maintain effective antioxidant defense mechanisms. We aimed to show the relationship between sepsis and thiol-disulfide homeostasis in newborns. MATERIALS AND METHODS: In this prospective study, 66 newborns with sepsis (group 1) and 51 healthy controls (group 2) were included. In group 1, 53 newborns were diagnosed as clinical sepsis (group 1a) and 13 as definite sepsis (group 1b). The study has two time points; the day of diagnosis (step 1) and three days after the treatment (step 2). At step 1, group 1 and group 2 were compared for thiol-disulfide homeostasis as well as inflammatory markers. At step 2, the same laboratory tests were repeated only in group 1. RESULTS: At step 1, the levels of C-reactive protein (CRP) and interleukin-6 (IL-6) were higher, while native thiol and total thiol levels were lower in group 1 compared to controls. Serum disulfide/total thiol ratio was also significantly higher in group 1. When analyzed for subgroups of group 1, demonstration of microorganism did not affect the serum thiol levels. Within group 1, at step 2, although CRP and IL-6 levels were significantly lowered compared to step 1, we did not observe significant changes in thiol-disulfide parameters. CONCLUSIONS: The thiol-disulfide homeostasis may have a role in the pathogenesis of sepsis in newborns. The related parameters might be new markers for the diagnosis of sepsis in newborn patients. Further studies are needed to define the role of thiol-disulfide homeostasis in the course of neonatal sepsis.


Subject(s)
Disulfides , Neonatal Sepsis , Biomarkers/metabolism , Homeostasis , Humans , Infant, Newborn , Neonatal Sepsis/diagnosis , Oxidative Stress , Prospective Studies , Sulfhydryl Compounds
10.
J Matern Fetal Neonatal Med ; 34(10): 1634-1640, 2021 May.
Article in English | MEDLINE | ID: mdl-31296073

ABSTRACT

INTRODUCTION: Lung ultrasonography (LUS) is a noninvasive bed-side test and increasingly used by clinicians in the management and follow-up of respiratory distress syndrome (RDS) in premature infants. OBJECTIVE: To compare the results of three natural surfactants according to LUS scores in premature infants with RDS. METHODS: This was a prospective study on 62 preterm infants (25-34 weeks) with RDS and receiving surfactant according to 2016 European guidelines. All patients underwent a clinical evaluation and chest X-ray at three study points; at the first hours of life (presurfactant), and at 6-12th hour (early postsurfactant) and 24th hour (late postsurfactant) of surfactant. Simultaneously fractional inspired oxygen (FiO2) need, arterial PaO2 values, Downes and LUS scores were noted. The patients were randomized into three groups; Group 1 (n = 23), poractant alpha; Group 2 (n = 20), beractant; and Group 3 (n = 19), calfactant. The groups were compared according to clinical, laboratory and radiological variables as well as LUS scores. RESULTS: Gestational age (p = .05), birthweight (p = .07), and SNAPPE-II scores (p = .57) were similar in three groups. Repeated dose need was the highest in Group 3 (p = .04). FiO2 need (p = .04) was the highest and PaO2 values (p = .03) were the lowest at late postsurfactant point in the same group. LUS scores were also the highest in Group 3 at this period (p = .02). Downes scores were similar in groups at all points (p > .05). NICU stay were similar in groups (p = .53). The durations of total oxygen supplementation, mechanical ventilation, and hospital stay were the same in groups (p > .05). CONCLUSIONS: In newborns with RDS, poractant alpha and beractant have similarly reduced oxygen need in accordance to the LUS findings. However, they seem to be superior compared to calfactant.


Subject(s)
Respiratory Distress Syndrome, Newborn , Surface-Active Agents , Humans , Infant , Infant, Newborn , Infant, Premature , Lung/diagnostic imaging , Prospective Studies , Respiratory Distress Syndrome, Newborn/diagnostic imaging , Respiratory Distress Syndrome, Newborn/drug therapy , Ultrasonography
11.
Fetal Pediatr Pathol ; 40(3): 250-255, 2021 Jun.
Article in English | MEDLINE | ID: mdl-31755792

ABSTRACT

BACKGROUND: Necrotizing enterocolitis (NEC) is one of the most important life- threatening diseases in neonates. Recurrent episodes of supraventricular tachycardia (SVT) can lead to gut ischemia, with subsequent reperfusion injury resulting in NEC. Mesenchymal stem cells (MSCs) are multi-potential cells which can differentiate into multiple cell types. Case report: A 22-day old male baby delivered to 34 yr old mother at 37-weeks' gestation via cesarean section, birth weight 3550 g, developed NEC 14 hours after being treated with cardioversion for SVT. At laparotomy, there was pan-NEC, and 60 cm of necrotic and perforated bowel was resected. 1 × 107 umbilical cord origin allogeneic MSCs were given intravenously, with subsequent improvement of the remaining bowel. Conclusion: MSC may be a promising treatment for adjacent ischemic bowel in NEC helping prevent short bowel syndrome.


Subject(s)
Enterocolitis, Necrotizing , Intestinal Perforation , Mesenchymal Stem Cells , Tachycardia, Supraventricular , Cesarean Section , Enterocolitis, Necrotizing/etiology , Female , Humans , Infant , Infant, Newborn , Male , Pregnancy , Tachycardia, Supraventricular/etiology , Tachycardia, Supraventricular/therapy
12.
Indian Pediatr ; 56(9): 735-740, 2019 09 15.
Article in English | MEDLINE | ID: mdl-31638004

ABSTRACT

OBJECTIVE: Vasoactive-inotropic Score (VIS) was developed to quantify the amount of inotropic support provided in the postoperative period. We investigated the predictive value of (VIS) for mortality in neonates with congenital heart disease (CHD). STUDY DESIGN: Prospective cohort. PATIENTS: 119 newborns who underwent cardiac surgery. SETTING: Tertiary NICU-CHD center of Ankara from November 2016 to January 2019. INTERVENTION/MEASUREMENT: VIS values were calculated by a standard formula for the first 72 postoperative hours, and the maximum score was recorded. PRIMARY OUTCOMES: Duration of mechanical ventilation, NICU length of stay, and mortality. RESULTS: At surgery, the median (IQR) age was 15 d (9-31). The patients were divided into two groups according to mortality; Group 1 (Non-survivors) (n=36) and Group 2 (Survivors) (n=83). Higher VIS score was correlated to longer duration of mechanical ventilation (P=0.009, r=0.33), and was higher among patients who died (P=0.003). Area under the curve (AUC) was 0,83 (P<0.001, CI: 95% 0.7-0.9) for VIS to identify mortality. At a cut-off value of 15.5, sensitivity and negative predictive values of VIS for mortality were 73.6% and 85.3%, respectively. The higher VIS (>15.5) was independently associated with increased odds for mortality (OR: 8.1, 95% CI: 1.8-35.7, P=0.005). CONCLUSIONS: In newborns with CHD, a higher VIS within 72 hours after cardiac surgery is associated with increased duration of mechanical ventilation, and mortality. VIS may be useful for prediction of mortality at early postoperative period.


Subject(s)
Cardiac Surgical Procedures/mortality , Clinical Decision Rules , Heart Defects, Congenital/surgery , Severity of Illness Index , Female , Follow-Up Studies , Heart Defects, Congenital/mortality , Humans , Infant, Newborn , Length of Stay/statistics & numerical data , Male , Predictive Value of Tests , Prospective Studies , Respiration, Artificial/statistics & numerical data , Sensitivity and Specificity , Survival Analysis , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...